Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong
· Delayed Price · Currency is HKD 41.94
+1.48 (3.66%)
At close: Dec 5, 2025
HKG:3692 Revenue
Hansoh Pharmaceutical Group Company had revenue of 7.43B CNY in the half year ending June 30, 2025, with 64.78% growth. This brings the company's revenue in the last twelve months to 13.19B, up 9.02% year-over-year. In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B with 21.35% growth.
Revenue (ttm)
13.19B CNY
Revenue Growth
+9.02%
P/S Ratio
17.57
Revenue / Employee
1.47M CNY
Employees
8,989
Market Cap
253.90B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 38.69B |
| JD Health International | 71.34B |
| Innovent Biologics | 12.52B |
| WuXi Biologics | 21.98B |
| Sino Biopharmaceutical | 33.49B |
| Akeso | 2.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |
| CSPC Pharmaceutical Group | 28.65B |
Hansoh Pharmaceutical Group Company News
- 5 weeks ago - Innovent's License Deal Fails To Excite investors - Benzinga